human

(redirected from coagulation factor IX)
Also found in: Dictionary, Medical, Legal, Encyclopedia.
Related to coagulation factor IX: coagulation factor VIII
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • all
  • adj
  • noun

Synonyms for human

Synonyms for human

of or characteristic of human beings or mankind

Synonyms

concerned with human welfare and the alleviation of suffering

Synonyms for human

References in periodicals archive ?
Without limited choices, it means that the coagulation factor IX needs to be represented as a number, then any mutation would leads this number to change.
In this study, we use our approach to building a descriptively probabilistic relationship between mutated primary structure of coagulation factor IX and clinical severity of hemophilia B.
The human coagulation factor IX precursor with total 145 mutations is obtained from UniProtKB/Swiss-Prot entry [27].
examines applications of Coagulation Factor IX and its consumers
provides Coagulation Factor IX market situation overview and supplies with a list of Coagulation Factor IX manufacturers and suppliers worldwide
Lot 1 - blood coagulation Factor VIII Rights (Imunat 500 IU or equivalent) - 37 fl Lot 2 - Coagulation Factor IX blood human child (Aimafiks 500 IU or equivalent) - 42 fl
Food and Drug Administration today approved Idelvion, Coagulation Factor IX (Recombinant), Albumin Fusion Protein, for use in children and adults with Hemophilia B.
GTC", Nasdaq: GTCB) announced today that LFB Biotechnologies has agreed to include the recombinant human coagulation factor IX program in the existing collaboration between GTC and LFB.
GTC previously obtained from ProGenetics an exclusive license to a number of recombinant plasma proteins, including human coagulation factor IX, for North America, Europe and Japan.
Tenders are invited for Acquisition Nonacog Alpha Coagulation Factor Ix
Procurement Acquisition Nonacog Alpha Coagulation Factor Ix, the Largest Estimated Value of the Subsequent Contract for Lot 1 Is 23610 Lei for Lot 2 Is 844 000 for Lot 3 Is 288 700 Lei.
Biovitrum (STO:BVT) today announced it has entered into a new agreement, effective August 8, 2007, with Wyeth (NYSE:WYE) to co-promote BeneFIX[R], Coagulation Factor IX (Recombinant) for hemophilia B, in the Nordic countries (Denmark, Finland, Iceland, Norway and Sweden).
2 Concentrate recombinant coagulation factor IX least second generation delivered to the patient~s home / to the hemophilia treatment center.
2, ATC code: B02BD01, Generic Name: Coagulation Factor IX, II, VII and X in combination Pharmaceutical form: Infusion Strength: 1000 IU, Unit 350 U, Quantity in units: 10thThe above drugs provided under contract number each independently of the other drugs.
Hemophilia B (Christmas disease) is a rare, potentially life threatening, congenital bleeding disorder resulting from a defect or deficiency in blood coagulation factor IX.